| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 47 Number 1
Volume 46 Number 6
Volume 46 Number 5
Volume 46 Number 4
Volume 46 Number 3
Volume 46 Number 2
Earlier issues
Volume 46 Number 1 Volume 46 Number 2 Volume 46 Number 3

previous article next article

Research articles

ScienceAsia 46 (2020): 206-212 |doi: 10.2306/scienceasia1513-1874.2020.022

Changes in TLR-4 expression level and CD14+CD16+ monocyte ratio in the peripheral blood of patients with early diabetic nephropathies

Yu Chena,*, Kun Menb, Chun-mei Menga, Jing Maa, Jian-chao Guoa

ABSTRACT:     Cytokine-mediated activation of chronic microinflammatory and nonspecific immune responses plays an important role in the progression of early diabetic nephropathy (EDN). The purpose of this study was to investigate Toll- like receptor 4 (TLR-4) levels in monocytes and the CD14+CD16+ monocyte ratios in peripheral blood from diabetic patients with EDN. One hundred and eighty-eight patients with type 2 diabetes mellitus were recruited and divided into 3 groups according to their microalbumin (mALB) content: (1) A-group (mALB < 30 mg/24 h, n=60); (2) B-group (mALB 30300 mg/24 h, n=64), which was further divided into the losartan potassium treatment group (B-T-group) and the untreated group (B-NT-group); and (3) C-group (mALB > 300 mg/24 h, n=64). Additionally, samples from 50 healthy patients were collected as the control group (N-group). Immune turbidimetric assays were used to measure high-sensitivity C-reactive protein (hsCRP) levels in serum. The levels of interleukin 6 (IL-6) in serum were detected by ELISA. CD14+CD16+ monocyte ratios and TLR-4 levels in monocytes were assessed by flow cytometry. There was no significant difference in the levels of hsCRP, IL-6, and TLR-4 and the CD14+CD16+ monocyte ratios between the A-group and N-group. The hsCRP, IL-6, TLR-4 and CD14+CD16+ monocyte levels in the B-group and C-group were notably higher than those in the A-group or N-group. Furthermore, compared with levels in the B-NT-group, TLR-4 and CD14+CD16+ monocyte levels were significantly decreased in the B-T-group. TLR-4 and CD14+CD16+ monocyte levels were increased in patients with EDN and restored with losartan potassium treatment, and the monocyte levels were positively correlated with the decrease in mALB. The TLR-4 level in monocyte and CD14+CD16+ monocyte ratio can be used as new targets for the early diagnosis of clinical diabetic nephropathy.

Download PDF

6 Downloads 360 Views

a Department of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin 300211 China
b Department of Clinical Laboratory, The Second Hospital of Tianjin Medical University, Tianjin, China

* Corresponding author, E-mail: yu_chen_666@126.com

Received 16 May 2019, Accepted 17 Mar 2020